NCI, Inc. (NASDAQ:NCIT) has a deal in place to acquire CSC (NYSE:CSC) subsidiary AdvanceMed Corporation.
AdvanceMed focuses on healthcare program integrity services specifically in the area of the detection and prevention of fraud, waste, and abuse in healthcare programs.
NCI expects the deal to close in early April. Additional details were not disclosed.
“The Obama administration has emphasized reducing fraud, waste, and abuse in federal entitlements, ” CEO Charles Narang. “AdvanceMed is ideally positioned to support the program integrity initiatives of CMS and other federal government agencies. They have a strong management and professional team with a solid contract backlog. We are extremely pleased to have AdvanceMed join NCI and believe that this acquisition will provide NCI an outstanding platform to address this rapidly growing market opportunity.”